The Science Behind our Program

NeuroBody’s approach is rooted in scientific research showing that movement, rhythm, and structured physical activity can improve cognitive function, emotional health, and overall wellbeing.

Our programs are built on decades of evidence linking consistent movement to improved brain performance, mood regulation, and quality of life — especially for adults experiencing cognitive or emotional decline.

1. Dance and the Brain — Harvard Medical School

Harvard researchers have shown that dance uniquely stimulates multiple brain regions responsible for memory, balance, coordination, and emotion.
By combining music, rhythm, movement, and social interaction, dance activates networks across the brain that support learning and neuroplasticity — the ability to form new neural connections and maintain cognitive performance over time.
These findings highlight how structured movement can help protect against age-related decline and strengthen both cognitive and emotional resilience.

2. The EXERT Study (Alzheimer’s & Dementia, 2025)

A major 18-month randomized clinical trial led by Wake Forest University and the University of California found that regular exercise helped adults with mild cognitive impairment (MCI) maintain stable cognition and brain volume.
Participants showed no measurable decline in memory or executive function after a year of consistent movement training.
Both aerobic and balance-based programs were equally effective at slowing hippocampal shrinkage and maintaining healthy biomarker levels related to Alzheimer’s disease.
The study also found that social interaction and guided participation played an important role in maintaining motivation and cognitive stability.
(Source: Baker et al., 2025, Alzheimer’s & Dementia Journal)

3. Dance Therapy Research in Dementia and Alzheimer’s

Independent clinical findings show that dance-based therapy can improve mood, attention, and mobility in adults with dementia and Alzheimer’s.
Movement combined with rhythm, coordination, and emotional connection supports brain regions linked to memory and emotional processing — helping participants feel more engaged, balanced, and confident.

Our Research Commitment

Building on this foundation, NeuroBody Therapeutics will conduct multiple clinical studies in 2026, in collaboration with medical advisors and academic partners.

Our research will focus on:

  • Mild Cognitive Impairment (MCI): Measuring the effects of structured movement therapy on cognition, balance, and neurobiological markers.

  • Depression and Emotional Health: Assessing how rhythmic, socially engaging exercise can improve mood regulation and reduce symptoms of depression.

  • Long-Term Functional Wellbeing: Evaluating overall mobility, confidence, and quality-of-life outcomes from regular participation in NeuroBody programs.

These studies will form the foundation of NeuroBody’s evidence-based model, helping validate our therapies for future integration with clinical care, insurance partnerships, and national health programs.